Authors:
Op de Coul, ELM
Prins, M
Cornelissen, M
van der Schoot, A
Boufassa, F
Brettle, RP
Hernandez-Aguado, I
Schiffer, V
McMenamin, J
Rezza, G
Robertson, R
Zangerle, R
Goudsmit, J
Coutinho, RA
Lukashov, VV
Citation: Elm. Op De Coul et al., Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997, AIDS, 15(2), 2001, pp. 257-266
Authors:
Parpia, T
Raab, GM
Goldberg, DJ
Allardice, GM
McMenamin, J
Whitelaw, J
McSharry, C
Potts, R
Herriot, R
Citation: T. Parpia et al., Effect of combination therapy on immunologic progression of human immunodeficiency virus at a population level, AM J EPIDEM, 153(9), 2001, pp. 898-902
Citation: Km. Roy et J. Mcmenamin, Hepatocellular carcinoma associated with chronic hepatitis B and C: pathogenesis, treatment and prevention, REV MED MIC, 11(3), 2000, pp. 171-178
Authors:
Goldberg, D
Johnston, J
Cameron, S
Fletcher, C
Stewart, M
McMenamin, J
Codere, G
Hutchinson, S
Raeside, F
Citation: D. Goldberg et al., Risk of HIV transmission from patients to surgeons in the era of post-exposure prophylaxis, J HOSP INF, 44(2), 2000, pp. 99-105
Authors:
Taylor, A
Goldberg, D
Hutchinson, S
Cameron, S
Gore, SM
McMenamin, J
Green, S
Pithie, A
Fox, R
Citation: A. Taylor et al., Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?, J INFECTION, 40(2), 2000, pp. 176-183
Authors:
Cameron, SO
Wilson, KS
Good, T
McMenamin, J
McCarron, B
Pithie, A
Fox, R
Citation: So. Cameron et al., Detection of antibodies against hepatitis C virus in saliva: a marker of viral replication, J VIRAL HEP, 6(2), 1999, pp. 141-144